BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2083556)

  • 1. Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.
    Chetanneau A; Baum RP; Lehur PA; Liehn JC; Perkins AC; Bares R; Bourguet P; Herry JY; Saccavini JC; Chatal JF
    Eur J Nucl Med; 1990; 17(5):223-9. PubMed ID: 2083556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies.
    Chetanneau A; Lehur PA; Ripoche D; Peltier P; Saccavini JC; Vuillez JP; Tournemaine N; Thedrez P; Chatal JF
    Eur J Nucl Med; 1989; 15(6):302-6. PubMed ID: 2670570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoscintigraphy of adenocarcinomas by means of 111In-labelled F(ab')2 fragments of anti-CEA monoclonal antibody F023C5.
    Riva P; Paganelli G; Callegaro L; Bartoli MG; Turci D; Benini S; Deleide G; Scassellati GA; Viale G; Siccardi AG
    Nucl Med Commun; 1988 Aug; 9(8):577-89. PubMed ID: 3173916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early immunoscintigraphic localisation of a mediastinal tumour with indium 111-DTPA CEA-specific F(ab')2 monoclonal antibody fragments (BW 431/31) using second tracer isocontour technique.
    Frohn J; Baum RP; Happ J; Falk S; Riemann HE; Hör G
    Eur J Nucl Med; 1990; 17(1-2):91-3. PubMed ID: 2083548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125.
    Baum RP; Lorenz M; Hottenrott C; Albrecht M; Senekowitsch R; Happ J; Hertel A; Spitz J; Hör G
    Int J Biol Markers; 1988; 3(3):177-84. PubMed ID: 3230337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CEA immunoscintigraphy might be more useful than computed tomography in the preoperative thoracic evaluation of lung cancer. A comparison between planar immunoscintigraphy, single photon emission computed tomography (SPECT), and computed tomography.
    Buccheri G; Biggi A; Ferrigno D; Leone A; Taviani M; Quaranta M
    Chest; 1993 Sep; 104(3):734-42. PubMed ID: 8365283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up.
    Lacić M; Bokulić T; Lukac J; Baum RP; Kusić Z
    Nucl Med Commun; 1999 Sep; 20(9):859-65. PubMed ID: 10533193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody.
    Faivre-Chauvet A; Mease RC; Chetanneau A; Bardiès M; Sai-Maurel C; Meinken GE; Srivastava SC; Chatal JF; Gestin JF
    Nucl Med Commun; 1996 Sep; 17(9):781-9. PubMed ID: 8895905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
    Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP
    J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoscintigraphy with 111In labelled monoclonal antibody fragments (F(ab')2 BW 431/31) against CEA: radiolabelling, antibody kinetics and distribution, findings in tumour and non-tumour patients.
    Bares R; Fass J; Truong S; Buell U; Schumpelick V
    Nucl Med Commun; 1989 Sep; 10(9):627-41. PubMed ID: 2616103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoscintigraphy of colorectal carcinomas with radiolabeled monoclonal antibody fragments.
    Obradovic V; Artiko V; Petrovic M; Stefanovic B; Krivokapic Z; Zuvela M; Stojkovic M; Stefanovic B; Milovanovic A; Vlajkovic M
    Hepatogastroenterology; 2006; 53(70):526-30. PubMed ID: 16995454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?
    Fuster D; Maurel J; Muxí A; Setoain X; Ayuso C; Martín F; Ortega ML; Fuertes S; Pons F
    Q J Nucl Med; 2003 Jun; 47(2):109-15. PubMed ID: 12865871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer.
    Volpe CM; Abdel-Nabi HH; Kulaylat MN; Doerr RJ
    Ann Surg Oncol; 1998 Sep; 5(6):489-94. PubMed ID: 9754756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoscintigraphy of recurrences of gynecologic carcinomas.
    Chatal JF; Fumoleau P; Saccavini JC; Thedrez P; Curtet C; Bianco-Arco A; Chetanneau A; Peltier P; Kremer M; Guillard Y
    J Nucl Med; 1987 Dec; 28(12):1807-19. PubMed ID: 3500284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis using monoclonal antibody imaging in the clinical follow-up of colorectal cancer].
    Campos Villarino LM; Pajares Vinardell M; Freire Macias JM; Vale Gonsalves EI; Millán Núñez-Cortés J; Senra Varela A
    An Med Interna; 1991 Aug; 8(8):377-81. PubMed ID: 1768746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
    Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
    Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoscintigraphy of adenocarcinomas by means of radiolabeled F(ab')2 fragments of an anti-carcinoembryonic antigen monoclonal antibody: a multicenter study.
    Siccardi AG; Buraggi GL; Callegaro L; Colella AC; De Filippi PG; Galli G; Mariani G; Masi R; Palumbo R; Riva P
    Cancer Res; 1989 Jun; 49(11):3095-103. PubMed ID: 2655889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of immunoscintigraphy in colorectal cancer--results of 5 years' clinical experiences.
    Hölting T; Schlag P; Georgi P
    Eur J Surg Oncol; 1990 Aug; 16(4):312-8. PubMed ID: 2199223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging lung cancer by scintigraphy with Indium 111-labeled F(ab')2 fragments of the anticarcinoembryonic antigen monoclonal antibody FO23C5.
    Buccheri G; Biggi A; Ferrigno D; D'Angeli B; Vassallo G; Leone A; Taviani M; Comino A
    Cancer; 1992 Aug; 70(4):749-59. PubMed ID: 1643607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma.
    Vuillez JP; Moro D; Brambilla E; Brichon PY; Ferretti G; Saccavini JC; Brambilla C
    Eur J Cancer; 1994; 30A(8):1089-92. PubMed ID: 7654435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.